Mazen S. Bader
- Epidemiology top 5%
- Infectious Diseases top 10%
- Molecular Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 10%
- Pulmonary and Respiratory Medicine
- Co-authors
- Annie BrooksMark LoebJohn HawboldtDaniela LetoDavid S. McKinseyDaniel R. HinthornSue Min LaiBabak Mokhlesi
- Topics
- Pneumocystis jirovecii pneumonia detection and treatment (5 papers)Antimicrobial Resistance in Staphylococcus (5 papers)Streptococcal Infections and Treatments (5 papers)
- Partner nations
- CanadaUnited StatesRussia
In The Last Decade
Mazen S. Bader
35 papers receiving 820 citations
Peers
Comparison fields: 5 of 103
- Epidemiology 484
- Infectious Diseases 150
- Molecular Medicine 147
- Endocrinology, Diabetes and Metabolism 121
- Pulmonary and Respiratory Medicine 94
Countries citing papers authored by Mazen S. Bader
This map shows the geographic impact of Mazen S. Bader's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mazen S. Bader with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mazen S. Bader more than expected).
Fields of papers citing papers by Mazen S. Bader
This network shows the impact of papers produced by Mazen S. Bader. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mazen S. Bader. The network helps show where Mazen S. Bader may publish in the future.
Co-authorship network of co-authors of Mazen S. Bader
This figure shows the co-authorship network connecting the top 25 collaborators of Mazen S. Bader. A scholar is included among the top collaborators of Mazen S. Bader based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mazen S. Bader. Mazen S. Bader is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 13 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 47 | |
| 7 | 7 | |
| 8 | 10 | |
| 9 | 4 | |
| 10 | 77 | |
| 11 | 6 | |
| 12 | 13 | |
| 13 | 8 | |
| 14 | 21 | |
| 15 | 11 | |
| 16 | 37 | |
| 17 | 14 | |
| 18 | 29 | |
| 19 | 22 | |
| 20 | 28 |
About Mazen S. Bader
Mazen S. Bader is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Clinical Biochemistry, having authored 36 papers that have together received 858 indexed citations. Recurring topics across this work include Pneumocystis jirovecii pneumonia detection and treatment (5 papers), Antimicrobial Resistance in Staphylococcus (5 papers) and Streptococcal Infections and Treatments (5 papers). The work is most often cited by research in Molecular Medicine (147 citations), Applied Microbiology and Biotechnology (48 citations) and Epidemiology (484 citations). Mazen S. Bader has collaborated with scholars based in Canada, United States and Russia. Frequent co-authors include Annie Brooks, Mark Loeb, John Hawboldt, Daniela Leto, David S. McKinsey, Daniel R. Hinthorn, Sue Min Lai, Babak Mokhlesi, H Fredlund and Hans‐Christer Holmberg. Their work appears in journals such as CHEST Journal, The Lancet Infectious Diseases and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.